UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051253
Receipt number R000058448
Scientific Title Prospective Interventional Study Examining the Effectiveness of Virtual-pet Assisted Therapy in Long COVID Patients
Date of disclosure of the study information 2023/06/10
Last modified on 2024/05/01 15:51:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective Interventional Study Examining the Effectiveness of Virtual-pet Assisted Therapy in Long COVID Patients

Acronym

Prospective Interventional Study Examining the Effectiveness of Virtual-pet Assisted Therapy in Long COVID Patients

Scientific Title

Prospective Interventional Study Examining the Effectiveness of Virtual-pet Assisted Therapy in Long COVID Patients

Scientific Title:Acronym

Prospective Interventional Study Examining the Effectiveness of Virtual-pet Assisted Therapy in Long COVID Patients

Region

Japan


Condition

Condition

Long COVID

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Animal therapy has long been proven to increase happiness and improve loneliness. However, virtual animal therapy has so far proven to be less effective, and since Long-COVID patients often experience some psychological symptoms, we decided to investigate whether virtual animal therapy could improve Long COVID symptoms, considering its feasibility during the COVID-19 epidemic. The feasibility of this project led us to investigate the effect of virtual animal therapy to see if it could improve the symptoms of Long COVID.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Happiness (Satisfaction With Life Scale)
Sleep quality (Athens Sleep Scale)
COVID-19 symptoms

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

After consenting, study subjects will participate at the usual intervals of 2, 4, and 6 months between outpatient visits. All visits will be scheduled on the same day as the outpatient visits and will not be for research purposes only. If the outpatient visits are completed during the course of the study, the study will be terminated at that time. After obtaining research consent, a questionnaire will be administered before and after each Virtual Assisted Animal Therapy (VAT) session.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients over 18 years of age attending the Department of General Medicine, Juntendo University Hospital, Juntendo University School of Medicine, with regard to Long COVID.
2. Patients who have received a full explanation of their participation in this study, and who have given written consent of their own free will based on a thorough understanding of the study.

Key exclusion criteria

1. Persons with dizziness to the extent that they have difficulty standing
2. Persons with claustrophobia
3. Persons with communication problems due to cognitive decline, etc.
4. When the principal investigator and principal investigator(s) determine that discontinuation of the study is appropriate for other reasons

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Miyagami
Middle name Yamashita,
Last name Taiju

Organization

Juntendo University Faculty of Medicine

Division name

Department of General Medicine

Zip code

113-8421

Address

2-1-1, Hongo, Bunkyo-Ku, Tokyo, Japan

TEL

08050657077

Email

miya0829gami@gmail.com


Public contact

Name of contact person

1st name Miyagami
Middle name
Last name Taiju

Organization

Juntendo University Faculty of Medicine

Division name

Department of General Medicine

Zip code

113-8421

Address

2-1-1, Hongo, Bunkyo-Ku, Tokyo, Japan

TEL

08050657077

Homepage URL


Email

miya0829gami@gmail.com


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

Juntendo University Faculty of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of the Faculty of Medicine, Department of Medicine, Soon Chun University

Address

2-1-1, Hongo, Bunkyo-Ku, Tokyo, Japan

Tel

0338133111

Email

tmiyaga@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 06 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2023 Year 06 Month 03 Day

Date of IRB

2023 Year 04 Month 07 Day

Anticipated trial start date

2023 Year 06 Month 14 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 06 Month 03 Day

Last modified on

2024 Year 05 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058448


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name